Guidance

Personalised Asthma Action Plans

As part of QOF, patients should have a Personalised Asthma Action Plan agreed when the patient attends for their annual asthma review.  The PAAP should include information about how to step-up and step-down inhalers, and how to respond to acute exacerbations.  It is important that when making these plans that patients understand what they are, and it is best to use the term Personalised Asthma Action Plan.

Pharmacies have a new Pharmacy Quality Scheme (PQS).  There are many domains in this PQS, one being respiratory.  As part of the respiratory domain pharmacies will be asking patients with asthma whether or not they have a Personalised Asthma Action Plan (PAAP).  If a patient reports that they do not have a PAAP, pharmacies will signpost the patients back to their GP practice.  To avoid confusion for the patient and reduce the instances of patients been sent back to practices, ensure that patients with asthma understand their PAAP.

First Published
25 August 2021
Updated On
15 August 2023
Due to be Reviewed
14 July 2025
Not signed in.

Please Login or Register an account to access the ability to favourite this.
Share this article

You might also find this useful...

QOF Point Value and Prevalence
QOF Point Value and Prevalence
13 August 2024
We often get asked how disease register prevalence and list size affects the value of QOF. This article explains how QOF is calculated using your practice prevalence data from NHS…
Cont. Reading
National MMR catch-up campaign
National MMR catch-up campaign
24 April 2024
This article provides clarification on the following MMR issues: Requests for bringing forward MMR doses. Requests for MMR doses in adults including HCWs. MMR requirements for GP Practice staff National…
Cont. Reading